Cell therapies are powerful technologies in which human cells are reprogrammed for
therapeutic applications such as killing cancer cells or replacing defective cells. The …

The greatest challenge in cancer therapy is to eradicate cancer cells with minimal damage
to normal cells. Targeted therapy has been developed to meet that challenge, showing a …

Umami peptides are small molecular weight oligopeptides that play a role in umami taste
attributes. However, the identification of umami peptides is easily limited by environmental …

Background: Chimeric antigen receptor (CAR) T-cell therapy is practical in treating cancers
of hematopoietic origin, but of that in solid tumors compromises efficacy for the loss of the …

Background aims Chimeric antigen receptor T (CAR-T) cells are a remarkably efficacious,
highly promising and rapidly evolving strategy in the field of immuno-oncology. The …

Chimeric Antigen Receptor (CAR) T cell therapies are tremendously successful in
hematological malignancies and show great promise as treatment and curative strategy for …

Simple Summary Pancreatic cancer is an insidious disease, often diagnosed late in its
course when curative treatments are moot, with a 5-year median overall survival of~ 12 …

Based on the concept of" Evolutionary Traps", targeting survival essential genes obtained
during tumor drug resistance can effectively eliminate resistant cells. While, it still faces …

Cellular immunotherapy has emerged as an exciting strategy for cancer treatment, as it aims
to enhance the body's immune response to tumor cells by engineering immune cells and …

As one of the most promising adoptive T-cell therapies, chimeric antigen receptor T-cell
(CAR-T) therapy has acquired Food and Drug Administration (FDA) approval for a variety of …